6-bromo-4-chromanone CAS-49660-57-3

Our organization has gained name and fame in offering 6-Bromo-4-Chromanone to our clients. This 6-Bromo-4-Chromanone has been synthesized in chemical reaction by making use of 6 molecules of bromine and 4 molecules of chromanone. This 6-Bromo-4-Chromanone is free from side effects and has got precise composition. It finds application in industries mostly as solvent. We are offering 6-Bromo-4-Chromanone at reasonable price.

Merck to pay $830 mn to resolve class action case over Vioxx

Merck, known as MSD outside the United States and Canada, announced that it has reached an agreement with plaintiffs to resolve In re Merck & Co., Inc. Securities Litigation, a multi-district class action lawsuit pending in New Jersey federal court. The settlement class consists of persons who purchased Merck securities during the period from May 21, 1999, through October 29, 2004, inclusive, and who seek to recover damages under the federal securities laws for certain Merck statements regarding Vioxx.

Under the agreement, Merck will pay $830 million to resolve the settlement class members’ claims, plus an additional amount for approved attorneys’ fees and expenses. After available funds under certain insurance policies, Merck’s cash payment for the settlement and fees will be approximately $680 million, for which the company will record a charge in the fourth quarter of 2015, which will be excluded from non-GAAP results. The agreement is subject to court approval.

The settlement does not constitute any admission by Merck or any of the individual defendants of any liability or wrongdoing.

Merck still faces previously disclosed individual securities lawsuits related to Vioxx.

SwastiChemEx - Product List

At SwastiChemEx, we Source raw materials from chemical suppliers all around the world and market them to manufacturers serving key industrial and consumer marketplaces.
These relationships are based on a long-standing chemicals expertise, exceptional follow-through and the fastest turnaround times in the business.
Our experience and expertise ensures your business gains significant competitive edge over competition.

Product List :- 

 6-bromo-4-chromanone    CAS No. (49660-57-3),
6-Bromo-2-methylquinoline    CAS No. (877-42-9),
6-Chloro-2-methylquinoline    CAS No. (92-46-6),
2-Amino-4,6-dichloropyrimidine     CAS No.(56-05-3),
6-Bromoveratraldehyde    CAS No.(5392-10-9),
5-cyno indole    CAS No. (15861-24-2),
6-Acetyl benzothiazin-3-one   CAS No. (133044-44-7),
2-Amino-4-(4-chlorophenyl)thiazole  CAS No.(2103-99-3),
4′-(4-Bromophenyl) acetophenone      CAS No. (5731-01-1),
1-Bromo-2-(2-methoxyethoxy) ethane   CAS No. (54149-17-6),
1-Boc piperzine-3-one    CAS No. (76003-29-7),
4-Bromo-O-Phenylenediamine     CAS No. (1575-37-7),
2-Chlorolepidine   CAS No. (634-47-9),
4-Chloro-ophenylenediamine CAS No. (95-83-0),
2-Chloro-3-quinolinecarboxaldehyde    CAS No. (73568-25-9),
4,4′-Dibromobenzophenone     CAS No. (3988-03-2),
2,3-Dichlorophenylpiperazine    CAS No. (41202-77-1),
2,3-Dibromofuran-5-carboxylic acid    CAS No. (2434-03-9),
1,3-dimethyluracil    CAS No.  (874-14-6),
4-Fluro-ophenylenediamine      CAS No. (367-31-7),
Methyl 2-(3,4-dihydro-3-oxo-2H-benzo[b][1,4]oxazin-2-yl)acetate   CAS No. (73219-44-0),
Methyl 3-amino-p-toluate   CAS No. (18595-18-1),
Methyl [2H-1,4-benzothiazin-3(4H)-one-2-yl] acetate  CAS No. (7556-63-0),
2-Hydrazono-3-methylbenzothazolinehydrchloride    (MBTH) CAS No. ( 149022-15-1),
2-Mercapto-5-methoxy benzimidazole   CAS No. (55690-60-3),
4-{(4-Methylpiperazin-1-yl)methyl) benzoic acid  CAS No.  (106261-48-7),
6-Nitroveratryl alcohol   CAS No. (1016-58-6),
6-Nitroveratryl aldehyde     CAS No. (20357-25-9),
6-Fluro-2-methylquinoline    CAS No. (1128-61-8),
Indole-6-carboxylicacid methyl ester CAS No. (50820-65-0),
3-Bromo-(2-bromomethyl) propionicacid  CAS No. (41459-42-l),
2-Chloro-6-methylpyridine-4-carboxylicacid  CAS No. (25562-85-5),
N-Ethyl Thiourea  CAS No. (625-53-6),
2-Amino-6-bromopyridine   CAS No. (19798-81-3),

Platform, a Chemicals Firm, to Buy U.K. Rival

The chemicals empire of serial acquirer Martin E. Franklin is about to expand further.

Platform Specialty Products Corp. of the U.S. is nearing a deal to buy U.K.-listed specialty-chemicals maker Alent PLC for about $2.3 billion, according to people familiar with the matter. The transaction is expected to be announced Monday, the people said.

Platform is to pay 503 pence ($7.80) per share for Alent, with 78% of the consideration in cash and 22% in shares, the people said. That is 49% above Alent’s closing price Friday of 337.7 pence.

With the backing of heavyweights including William Ackman, Mr. Franklin created Platform in 2013 as a vehicle to buy specialty-chemicals companies. It is a familiar strategy for the 50-year-old Mr. Franklin, who acquired niche consumer-products brands to build Jarden Corp. and more recently launched frozen-foods business Nomad Holdings Ltd. Separately, Mr. Franklin’s Jarden is close to acquiring packaging-goods maker Waddington Group for $1.35 billion from buyout firm Olympus Partners, said a person familiar with the matter. That news was reported earlier by Bloomberg.